We are live on
!
Find out more
Edgewood Management Portfolio holdings
AUM
$15.5B
1-Year Est. Return
9.67%
This Fund
S&P 500
This Quarter
Est. Return
+13.95%
1 Year Est. Return
+9.67%
3 Year Est. Return
+69.33%
5 Year Est. Return
+71.36%
10 Year Est. Return
+535.67%
AUM
$17.9B
AUM Growth
+$2.73B
(+18%)
Cap. Flow
+$642M
Cap. Flow
% of AUM
3.58%
Top 10 Holdings %
Top 10 Hldgs %
54.98%
Holding
85
New
1
Increased
20
Reduced
31
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$183M |
| 2 |
CME Group
CME
|
+$182M |
| 3 |
NVIDIA
NVDA
|
+$114M |
| 4 |
Amazon
AMZN
|
+$45.8M |
| 5 |
CELG
Celgene Corp
CELG
|
+$42.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$140M |
| 2 |
Illumina
ILMN
|
+$99.4M |
| 3 |
S&P Global
SPGI
|
+$51M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.71M |
| 5 |
3M
MMM
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.64% |
| 2 | Healthcare | 20.37% |
| 3 | Communication Services | 16.39% |
| 4 | Consumer Discretionary | 16.34% |
| 5 | Technology | 8.67% |
Similar funds
EH
NMO
OAC
RFC
EF
LCIP
Edgewood Management's Q1 2017 Portfolio in Review
As of Q1 2017, Edgewood Management held 85 positions worth $17.9B, up 18% from $15.2B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Edgewood Management deployed $642M of net new capital in Q1 2017, opening 1 new position and adding to 20 existing holdings. Its largest new stake was Equifax: 1,497 shares worth $205K.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Charles Schwab, an estimated $140M trimmed.
- Edgewood Management's largest Q1 2017 buy was Equifax: 1,497 shares worth $205K.
- Edgewood Management added most to Intuitive Surgical in Q1 2017, an estimated $183M increase.
- Edgewood Management's biggest Q1 2017 reduction was Charles Schwab, cutting an estimated $140M.
- Edgewood Management fully exited Regeneron Pharmaceuticals in Q1 2017, selling an estimated $918K.
- Edgewood Management's ten largest holdings make up 55% of its $17.9B portfolio in Q1 2017.
- Edgewood Management opened 1 new position and closed 4 in Q1 2017.
- Edgewood Management's portfolio value rose 18% quarter-over-quarter to $17.9B.
Based on Edgewood Management's 13F filing for Q1 2017, filed 12 May 2017.